Mirae Asset Got Zero SpaceX Shares Despite Being an Underwriter. Regulators Are Now Looking at Why.

Since SpaceX priced its IPO at $135 per share on June 12, 2026 and listed on Nasdaq under the ticker SPCX, the story has moved well beyond the debut itself. The stock closed around $161 on its first trading day, roughly 19% above the offering price, and the company's post-debut valuation crossed $2 trillion, according to Crypto Briefing. What has emerged since is a structural dispute over who got shares and who got nothing.

Mirae Asset's Empty Basket

Mirae Asset Securities, a South Korean brokerage, was listed as an underwriter on the deal. That status did not translate into a single share to distribute. The IPO was 3.5 to 4 times oversubscribed, according to Crypto Briefing, meaning demand vastly exceeded the float. When the lead underwriters began allocating, Mirae Asset ended up with zero.

The lead underwriters were Goldman Sachs, Morgan Stanley, Bank of America, JPMorgan Chase, and Citigroup. Mirae Asset was NOT in that group. On June 15, Mirae Asset issued a public apology, citing decisions made by the U.S. lead underwriters as the cause. The firm's clients, who had expected access to one of the most anticipated market debuts in years, received refunds instead of shares.

A headline from the Finviz news feed, timestamped 2:00 AM ET on June 30, describes the situation as a "misunderstanding" between Mirae and the lead underwriters. Whether it was a miscommunication, a deliberate allocation choice, or something the system simply produced by design remains the central unresolved question.

The Case for the Lead Underwriters

The strongest defense of the U.S. banks is straightforward: in a deal this oversubscribed, someone had to get nothing. Lead underwriters in U.S. IPOs have broad discretion over allocation, and that discretion is standard practice, not a policy violation. In a 3.5-to-4x oversubscribed deal, even large participants get scaled back, and junior participants without direct client relationships to the issuer can be left out entirely. Mirae Asset's non-lead status, not any misconduct, may fully explain the outcome.

That said, the outcome has still drawn regulatory attention. Crypto Briefing reports that the Mirae Asset situation has opened discussions about potential compensation for affected clients and prompted formal scrutiny of how lead underwriters exercise allocation discretion when non-U.S. firms are involved in mega-scale deals.

Crypto Platforms Caught Short

The allocation failure rippled into the crypto market. Several platforms had offered clients tokenized exposure to SpaceX shares through Kraken's xStocks infrastructure before the IPO settled, anticipating they would secure actual shares post-offering. When the allocations didn't materialize, they had no underlying asset to tokenize. Bybit and Binance Wallet were among the platforms that canceled offerings entirely and returned funds to users, according to Crypto Briefing.

This is a concrete limit-case for the tokenized-equity model. The product only works if the platform can actually get the shares. In an oversubscribed IPO where even named underwriters walk away empty, platforms without direct underwriter relationships face a structural problem that no amount of blockchain infrastructure solves.

SpaceX's Bitcoin Treasury

Separate from the allocation dispute, SpaceX's S-1 filing disclosed a Bitcoin treasury of 18,712 BTC, valued at approximately $1.3 billion as of March 31, 2026. For traditional equity analysts accustomed to modeling aerospace and defense cash flows, that's an unusual line item. A $1.3 billion BTC position means the company's balance sheet will fluctuate with crypto market conditions independent of rocket launch cadence or Starlink subscriber growth.

This doesn't invalidate the business, but it does mean investors who bought SpaceX stock at $135 per share are also carrying indirect Bitcoin exposure whether they intended to or not.

What Comes Next

The regulatory review of Mirae Asset's zero-allocation outcome is the thread worth watching. If regulators conclude the U.S. lead underwriters acted within normal discretion, the precedent remains unchanged and non-U.S. firms continue to bear this risk in future mega-IPOs. If they find the process was opaque or unfair to secondary underwriters, the outcome could force disclosure reforms around how allocation decisions are made and documented in oversubscribed deals. Crypto Briefing notes that any formal review result could set precedents directly affecting how future large-scale IPOs handle secondary underwriter participation. No findings have been announced as of June 30, 2026.